Lipid Panel Assesses cardiovascular risk, which GLP-1 medications may improve over time
For researchers studying tirzepatide's dual GLP-1/GIP receptor mechanism, research-grade compounds are available for laboratory use at a fraction of pharmaceutical pricing
PlexusDx evaluates metabolic risk factors, not just BMI, to determine suitability for compounded semaglutide injection or other GLP-1 therapies
Their incorporation into preventive and therapeutic regimens, supported by rigorous scientific validation, holds the potential to transform the current landscape of NAFLD management and provide a foundation for safer and more personalized care
Learn More We have been in business for 15+ years
In some cases, combining the two therapies can yield complementary results, though cost and tolerability remain considerations